Antidepressant effects of ketamine and the roles of AMPA glutamate receptors and other mechanisms beyond NMDA receptor antagonism

Aleksandrova, Lily R., Phillips, Anthony G., Wang, Yu Tian·2017·Journal of Psychiatry and Neuroscience

Cited by (226)

Items 201–226 of 226

  1. Peripheral biomarkers in Repeated Ketamine Infusions Trial
    Amanda Van Geel · 2021 · Carleton University's Institutional Repository (MacOdrum Library, Carleton University)
  2. The use of psychoactive substances in the treatment of mental disorders
    Katarzyna Karaś-Ruszczyk, Katarzyna Groblińska, Krzysztof Szczygieł, Jerzy Samochowiec · 2021 · Alcoholism and Drug Addiction
  3. Introductory Chapter: Is Ketamine the New Panacea of the 21st Century?
    Nieves Sáiz‐Sapena, Manuel Granell · 2022 · IntechOpen eBooks
  4. Antidepressants and memory effects of ketamine under the neuromolecular view: A literature review
    Felipe Paes Gomes da Silva, Gabriel Rezende M, Lohana Pompeii Scapatici, de Araujo Luísa Zanelatto, Bruna Carrara Lombardi, Caroline Vidal, David Batista Wiedmer, Schoeler Lucas, Gisele Richter Minhoto, Roberto Andreatini · 2023 · Archives of Depression and Anxiety
  5. Ketamine for Traumatic Assault-Induced Depression: A Case Report
    Caitlyn B. Coffelt, Kyle Gibson, Jason VanLandingham · 2023 · Journal of Trauma Nursing
  6. The man who is confused about his identity
    Shiyu Chen · 2024 · Cambridge University Press eBooks
  7. N1 cassette-lacking NMDA receptors mediate the antidepressant activity of ketamine
    Alina Tao He, Wenbo Zhang, Hongbin Li, YuShan Tu, Dongju Lee, Doyeon Kim, Zhengping Jia, Lu‐Yang Wang, Michael W. Salter · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  8. Temporal Immune Effects of Oral Ketamine on PTSD: Transcriptomic Evidence of Short-Term Inflammation Suppression and Long-Term Immune Remodelling
    Nathan J Wellington, Bonnie L. Quigley, Ana Paula Bouças, Megan Dutton, Adem Can, Jim Lagopoulos, Anna Kuballa · 2025 · medRxiv
  9. Synthesis, crystal structure, DFT calculation, non-linear optical properties, and molecular docking studies of 7-chloro-3-methyl-2-(4-methylbenzyl)-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine 1,1-dioxide: the candidate as AMPA positive allosteric modulator
    Celal Tuğrul Zeyrek, Güler Toprak, Senem Akkoç · 2025 · Structural Chemistry
  10. The Effects of Ketamine on Methamphetamine Withdrawal-Induced Anxiety and Drug-Seeking Behaviors in the Rat
    Marco Ghilotti, Ricardo Petrilli Fortuna, Kofi Osei-Abrefa Ayensu, Danielle R. Stern, Ellen M. Unterwald · 2025 · Drug and Alcohol Dependence
  11. The Neuroplastic Narrative of Antidepressant Ketamine Involves Early and Sustained Effects that Counteract Mechanisms Underlying Stress, Inflammation, and Neurodegeneration
    August P. M. Lullau, Emily M. W. Haga · 2025 · Neuromethods
  12. The effects of low-dose ketamine and (2R,6R)-Hydroxynorketamine on affective behaviors associated with protracted oxycodone withdrawal
    Michael J. Lehane, Gregory C. Sartor · 2025 · Psychopharmacology
  13. The role of GABAergic receptors in acute, subacute, and withdrawal syndrome on pain and seizure thresholds in mice: A connection to mitochondrial function and oxidative stress in the brain
    Roghayeh Jahani, Paria Pourbahram, Mohammad Seyedabadi, Fatemeh Nasiri, Hamidreza Mohammadi · 2025 · Toxicology Reports
  14. Temporal immune effects of Oral ketamine on PTSD: Transcriptomic evidence of short-term inflammation suppression and sustained immune Remodelling
    Nathan J Wellington, Bonnie L. Quigley, Ana Paula Bouças, Megan Dutton, Adem Can, Jim Lagopoulos, Anna Kuballa · 2025 · Journal of Affective Disorders
  15. Ketamine as a prophylactic agent against post-traumatic stress disorder
    Julia Peavey · 2023 · Journal of High School Science
  16. Rôle des connexines 43 astrocytaires : une étude fonctionnelle dans un modèle murin de dépression basé sur le stress chronique
    Benjamin Portal · 2019 · theses.fr (ABES)
  17. Pharmacological augmentation in treatment-resistant depression: a neurobiologically informed, practical decision guide for treatment choice with lithium, quetiapine, or esketamine
    David Eckert, Siegfried F. Kasper · 2026 · International Journal of Psychiatry in Clinical Practice
  18. Pharmacological modulation of anxiety-like behavior by flumazenil, midazolam, and ketamine in rats: Evidence from aversive ultrasonic vocalizations and elevated plus maze
    Marcela Unterspann, Chrysostomos Charalambous, Martin Votava, LADISLAV HESS, Jiří Slíva, Marek Lapka · 2026 · Pharmacology Biochemistry and Behavior
  19. Efficacy and safety of perioperative esketamine in improving postoperative sleep disturbances: A systematic review and meta-analysis
    Xinyu Yang, T Y Gao, S Y Wang, Lingyue Hu, Fei Huang, Wei Cui, L Zhang · 2026 · Journal of Clinical Anesthesia
  20. Ketamine and Evolving Neuroplasticity
    Angel Prabakar · 2026 · Clinical Drug Investigation
  21. Psychedelics in treatment-resistant depression: a comprehensive review of mechanisms, clinical evidence, and recommendations
    Cielo Amelia Estela-Fernandez, Reem Mohamed Yousif Elsheikh, D F Beatrice, Abdullah A. Alhendal, Chinonso Irene Ewe, Sebastian Y. Montesinos, Jocelyn Wensel, Anushka P Mishra, Asma Ahmed Yousif, Hossam Tharwat Ali · 2026 · Neuropsychiatrie
  22. Prenatal Paroxetine Exposure Alters Oxidative, Inflammatory, Neurobehavioural, and Cholinergic Markers in the Hippocampus of Male and Female Mice Offspring in a Depression Model
    Israel Ofejiro Efejene, Benneth Ben-Azu, Anthony Taghogho Eduviere, Osuvwe C. Orororo, Mega Obukohwo Oyovwi, Michael Eromosele Aisuodionoe, Abdulwasiu A. Busari · 2026 · Emerging Frontiers in Translational Biomedicine and Health Sciences
  23. Ketamine Across the Dose–State Continuum: EEG Signatures, Network Dynamics, and Implications for Brain-State Monitoring in Anesthesia and Critical Care
    Vikas Chauhan, Fareena Khan · 2026 · Brain Sciences
  24. Ketamine Modulates Endogenous Opioid Peptide Signaling and Reduces Heroin-Seeking in Male Long-Evans Rats
    Adam M Dawoud, Achla Gupta, Ivone Gomes, Dylan Baker, Julia E Shapiro, Lakshmi Devi, Yasmin L. Hurd, Aya Osman · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  25. Integrating multi-receptor and neuron–glia mechanisms of ketamine's antidepressant action: a convergence framework for understanding efficacy
    Zuzanna Sulej, Magdalena Zielińska · 2026 · Frontiers in Molecular Neuroscience
  26. Exploring the durability of esketamine and ketamine's antidepressant effects in the maintenance phase of treatment: A systematic review
    Shreya Vasudeva, Diana K. Orsini, Gabrielle F. M. Lovell, Sara D Di Luch, Gia Han Le, Sabrina Wong, Roger S. McIntyre, Joshua Daniel Rosenblat · 2026 · Psychiatry Research